These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17922453)

  • 21. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.
    Lin JL; Lin-Tan DT; Yu CC; Li YJ; Huang YY; Li KL
    Kidney Int; 2006 Jun; 69(11):2049-56. PubMed ID: 16641918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc supplementation of chelation therapy in saturnism. Preliminary study.
    Bădulici S; Chirilă M
    Rom J Intern Med; 1992; 30(3):211-5. PubMed ID: 1475600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated body lead burden from drinking water in end-stage chronic renal failure.
    Kessler M; Durand PY; Hestin D; Cao Huu T; Renoult E; Prenat E; Chanliau J; Kaminski P; Duc M
    Nephrol Dial Transplant; 1995; 10(9):1648-53. PubMed ID: 8559484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated lead burden in Chinese patients without occupational lead exposure.
    Lin JL; Lim PS
    Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
    Lin JL; Ho HH; Yu CC
    Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Does lead cause renal damage? Surprising results published in a respected journal].
    Elinder CG
    Lakartidningen; 2003 May; 100(19):1736. PubMed ID: 12800302
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of extreme acute lead intoxication.
    Mikler J; Banovcin P; Jesenak M; Hamzikova J; Statelova D
    Toxicol Ind Health; 2009 Mar; 25(2):137-40. PubMed ID: 19458136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance and validity of a shortened lead chelation test.
    Apostoli P; Porru S; Duca P; Ferioli A; Alessio L
    J Occup Med; 1990 Nov; 32(11):1124-9. PubMed ID: 2124260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead poisoning in an adult: lead mobilization by pregnancy?
    Riess ML; Halm JK
    J Gen Intern Med; 2007 Aug; 22(8):1212-5. PubMed ID: 17562116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic lead poisoning like a group pathology. Clinical report of 12 cases].
    Mihalache C; Oprea V; Constantin B; Pintilie W; Teslariu E; Pal C
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):159-64. PubMed ID: 15688776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?
    Lin JL; Lim PS
    J Hum Hypertens; 1994 Jul; 8(7):495-500. PubMed ID: 7932512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A problem with her lead weight.
    Newton KE; Leonard M; Delves HT; Bowen-Jones D
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):145-8. PubMed ID: 15829126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lead poisoning in children. Apropos of 129 cases].
    Yver A; Leverger G; Iniguez JL; Gouraud F; Lamour C; Garnier R; Turbier C; Delour M; Lasfargues G
    Arch Fr Pediatr; 1991 Mar; 48(3):185-8. PubMed ID: 1904704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of chronic lead poisoning in CAPD patients.
    Kessler M; Durand PY; Hestin D; Gamberoni J; Chanliau J
    Adv Perit Dial; 1993; 9():143-6. PubMed ID: 8105909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
    Orfanos CE; Künzig M
    Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.